NX Prenatal Inc Press Releases

• Published on April 1, 2021 - 15:29 GMT

  

  NX Prenatal Announces Initiation of a Clinical Study for the Detection of Placenta Accreta

  Pregnant Moms with Prior C-Sections or Other Surgical Procedures at Heightened Risk LOUISVILLE, KY, UNITED STATES, April 1, 2021 /⁨EINPresswire.com⁩/ -- NX Prenatal Inc. (the “Company” or “NX Prenatal”), is pleased to announce it is a sponsor and …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on January 27, 2021 - 16:58 GMT

  

  NX Prenatal Expands Leading Patent Position in Exosome-Based Liquid Biopsy Tests in Maternal- Fetal Medicine

  LOUISVILLE, KY, UNITED STATES, January 27, 2021 /⁨EINPresswire.com⁩/ -- NX Prenatal Inc. (“NX Prenatal”) today announced that it has achieved new patent issuances in both the United States and Europe for its exosome-based liquid biopsy tests for the early …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on October 26, 2020 - 16:00 GMT

  

  NX Prenatal Announces Publication of First Trimester Exosome Liquid Biopsy Test Data for Preeclampsia Risk

  HOUSTON, TX, UNITED STATES, October 26, 2020 /⁨EINPresswire.com⁩/ -- NX Prenatal Inc. (“NX Prenatal”) today announced the publication of new data demonstrating that exosome-associated protein biomarkers derived from first trimester maternal plasma are key …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...